Average Co-Inventor Count = 4.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property (no.2) Limited (6 from 92 patents)
2. Smithkline Beecham Corporation (4 from 2,198 patents)
3. Glaxosmithkline LLC (3 from 356 patents)
4. Smithkline Beechman Corporation (1 from 7 patents)
5. Glaxosmithkline Intellectual Property Limited (0 patent)
14 patents:
1. 10064854 - Cyclopropylamines as LSD1 inhibitors
2. 9795597 - Cyclopropylamines as LSD1 inhibitors
3. 9790212 - Enhancer of zeste homolog 2 inhibitors
4. 9505745 - Enhancer of zeste homolog 2 inhibitors
5. 9346840 - Cyclopropylamines as LSD1 inhibitors
6. 8853408 - Cyclopropylamines as LSD1 inhibitors
7. 8058282 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
8. 7884098 - Anthranilamide inhibitors of aurora kinase
9. 7759486 - 2,4,5-Trisubstituted pyrimidine compounds
10. 7323472 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
11. 7314881 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
12. 7314934 - 4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
13. 7307097 - Chemical compounds
14. 7217710 - Substituted pyrazolopyrimidines